Ebastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C32H39NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TQD7Q784P1, chemically known as 1-butanone, 1-(4-(1,1-dimethylethyl)phenyl)-4-(4-(diphenylmethoxy)-1-piperidinyl)- but generally known as ebastine, which bears US NIH Compound Identifier 3191. European Medicines Agency schedules Ebastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06435MIG. The term EBASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules ebastine in its Anatomical Therapeutic Chemical (ATC) Classification. EBASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ebastine under HS 29333999 and SITC 51574. As of Q4 2014, EBASTINE remains the US FDA Preferred Term for this commodity. Ebastine bears US NLM identifiers UMLS ID C0058895 and NCI Concept Code C77437. SMILES: O(C1CCN(CC1)CCCC(=O)C1CCC(C(C)(C)C)CC1)C(C1CCCCC1)C1CCCCC1.